resveratrol has been researched along with Age-Related Macular Degeneration in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Acar, N; Aires, V; Bretillon, L; Chhuon, C; Courtaut, F; Delmas, D; Guerrera, IC; Olmiere, C; Pais de Barros, JP | 1 |
| Aires, V; Cornebise, C; Courtaut, F; Delmas, D; Hermetet, F; Olmiere, C; Perus, M; Scagliarini, A; Sghaier, R | 1 |
| Lai, JY; Luo, LJ; Nguyen, DD; Yang, CJ | 1 |
| Aires, V; Cornebise, C; Delmas, D; Hermetet, F; Perus, M; Richard, T; Valls-Fonayet, J | 1 |
| Alaimo, A; Chaufan, G; Di Santo, MC; Domínguez Rubio, AP; García Liñares, G; Pérez, OE | 1 |
| Kenney, MC; Kuppermann, BD; Nashine, S; Nesburn, AB | 1 |
| Abraldes, MJ; Caballero Arredondo, M; Calvo, P; Escobar-Barranco, JJ; Fernández-Robredo, P; García-Layana, A; Hernandez, M; Hernández-Galilea, E; Lopez-Sabater, MC; Mendez-Martínez, S; Nascimento, J; Olmedilla-Alonso, B; Pardiñas-Barón, N; Recalde, S; Silva, R; Zapata, MA | 1 |
| Cheng, YL; Lin, W; Qu, C; Wu, ZZ; Yang, Y | 1 |
| Baciu, P; Berchuck, JE; Jaffe, GJ; Ma, Z; Toimil, BA; Yang, P | 1 |
| Carroll, D; Podella, C; Richer, S; Stiles, W; Ulanski, L | 1 |
| Bee, YS; Chan, JY; Chen, SC; Lin, HC; Liu, NC; Ou, CC; Sheu, SJ | 1 |
| Cao, L; Liu, C; Wang, F; Wang, H | 1 |
| Lu, Y; Qin, S; Rodrigues, GA | 1 |
| Miller, L; Patel, S; Podella, C; Richer, S; Sockanathan, S; Ulanski, LJ | 1 |
| Fischer, T | 1 |
| Choung, SY; Kang, JH | 1 |
1 review(s) available for resveratrol and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls | 2015 |
1 trial(s) available for resveratrol and Age-Related Macular Degeneration
| Article | Year |
|---|---|
A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration.
Topics: Aged; Aged, 80 and over; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Nutrients; Phenylethyl Alcohol; Resveratrol; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins | 2021 |
14 other study(ies) available for resveratrol and Age-Related Macular Degeneration
| Article | Year |
|---|---|
RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization.
Topics: Animals; Choroidal Neovascularization; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Female; Macular Degeneration; Mice; Proteomics; Resveratrol | 2021 |
Resvega, a Nutraceutical Preparation, Affects NFκB Pathway and Prolongs the Anti-VEGF Effect of Bevacizumab in Undifferentiated ARPE-19 Retina Cells.
Topics: Bevacizumab; Dietary Supplements; Endothelial Growth Factors; Fatty Acids, Omega-3; Humans; I-kappa B Kinase; Macular Degeneration; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Retina; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2022 |
Highly Retina-Permeating and Long-Acting Resveratrol/Metformin Nanotherapeutics for Enhanced Treatment of Macular Degeneration.
Topics: Drug Delivery Systems; Humans; Macular Degeneration; Nanoparticles; Resveratrol; Retina; Retinal Diseases | 2023 |
Red Wine Extract Prevents Oxidative Stress and Inflammation in ARPE-19 Retinal Cells.
Topics: Humans; Hydrogen Peroxide; Inflammation; Macular Degeneration; Oxidative Stress; Resveratrol; Wine | 2023 |
Toxic effects of A2E in human ARPE-19 cells were prevented by resveratrol: a potential nutritional bioactive for age-related macular degeneration treatment.
Topics: Apoptosis; Cell Line; Cell Survival; Humans; Macular Degeneration; Magnetic Resonance Spectroscopy; Mitochondrial Dynamics; Reactive Oxygen Species; Resveratrol; Retinal Pigment Epithelium; Retinoids | 2020 |
Role of Resveratrol in Transmitochondrial AMD RPE Cells.
Topics: Aged; Aged, 80 and over; Antioxidants; Cell Line; Cell Nucleus; Cell Survival; Cells, Cultured; Dietary Supplements; Epithelial Cells; Fallopia japonica; Female; Humans; Macular Degeneration; Male; Mitochondria; Oxidative Stress; Plant Extracts; Reactive Oxygen Species; Resveratrol; Retinal Pigment Epithelium; Stilbenes; Vitis | 2020 |
Resveratrol protects against oxidative damage of retinal pigment epithelium cells by modulating SOD/MDA activity and activating Bcl-2 expression.
Topics: Apoptosis; Caspase 3; Cell Line; Cell Survival; Epithelial Cells; Humans; Hydrogen Peroxide; Macular Degeneration; Malondialdehyde; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; Retinal Pigment Epithelium; Superoxide Dismutase | 2019 |
All-trans-retinal sensitizes human RPE cells to alternative complement pathway-induced cell death.
Topics: Angiogenesis Inhibitors; Cell Death; Cells, Cultured; Complement Pathway, Alternative; Flow Cytometry; Humans; Macular Degeneration; Male; Middle Aged; Resveratrol; Retinal Pigment Epithelium; Ribonucleotide Reductases; Stilbenes | 2013 |
Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Asian People; Bevacizumab; Biomarkers; Choroidal Neovascularization; Dietary Supplements; Female; Humans; Macular Degeneration; Male; Ranibizumab; Resveratrol; Retina; Retinal Pigment Epithelium; Stilbenes; Vascular Endothelial Growth Factor A | 2013 |
Resveratrol stimulates mitochondrial bioenergetics to protect retinal pigment epithelial cells from oxidative damage.
Topics: Adult; Angiogenesis Inhibitors; Animals; Cell Survival; Cytoprotection; Disease Models, Animal; DNA Damage; Energy Metabolism; Enzyme Inhibitors; Female; Humans; Macular Degeneration; Mitochondria; Oxidative Stress; Rats; Rats, Inbred BN; Resveratrol; Retinal Pigment Epithelium; Stilbenes | 2013 |
SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway.
Topics: Adult; Amyloid beta-Peptides; Antioxidants; Blood-Retinal Barrier; Cell Survival; Enzyme Assays; Gene Silencing; Heterocyclic Compounds, 4 or More Rings; Humans; Inflammation; Interleukin-6; Interleukin-8; Macular Degeneration; Matrix Metalloproteinase 9; NF-kappa B; Primary Cell Culture; Real-Time Polymerase Chain Reaction; Resveratrol; Retinal Pigment Epithelium; RNA Interference; Signal Transduction; Sirtuin 1; Stilbenes | 2013 |
Resveratrol protects RPE cells from sodium iodate by modulating PPARα and PPARδ.
Topics: Angiogenesis Inhibitors; Antioxidants; Cells, Cultured; Cytoprotection; Gene Expression Regulation; Humans; Iodates; Macular Degeneration; PPAR alpha; PPAR delta; Resveratrol; RNA; Stilbenes | 2014 |
Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients.
Topics: Aged; Aged, 80 and over; Aging; Dietary Supplements; Female; Humans; Macular Degeneration; Male; Middle Aged; Nutritional Support; Resveratrol; Retina; Stilbenes; Time Factors; Treatment Outcome; Visual Acuity | 2014 |
Protective effects of resveratrol and its analogs on age-related macular degeneration in vitro.
Topics: Cell Death; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Macular Degeneration; Neuroprotective Agents; Resveratrol; Retinal Pigment Epithelium; Stilbenes | 2016 |